Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

150.77 USD UNCHANGED
Streaming Delayed Price Updated: 7:45 PM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Nasdaq Biotechnology Ishares ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AMPE JNJ ISEE
From Benzinga
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
The National Institutes of Health (NIH) hashalted a trial evaluating the safety and effectivenessof COVID-19 convalescent ... 
Tags KMDA ADMA Benzinga
From Benzinga
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SPPI BASI ATNX
From Benzinga
J&J’s Vaccine Rollout a Shot in the Arm for These Biotech ETFs
Biotech ETFs are climbing again on Monday, as the the CDC approved Johnson & Johnson’s coronavirus vaccine for emergency use this past weekend. The Centers for Disease Control and Prevention advisory... 
Tags IBB IYH FTXH
From ETF Trends
Stock ETFs Surge to Start March
Stocks and index ETFs are surging on Monday, as investors find relief from spiking Treasury yields last week, pushing inflationary concerns into the background to start the month. The Dow Jones... 
Tags SPY QQQ bond yields
From ETF Trends
Biotech Stocks Can Provide Growth and Value in a Volatile Market
Healthcare stocks lagged in February with the rebalancing. 
Tags Market News Healthcare Stocks / Equities
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags KNSA IBB FGEN
From Benzinga
Planning Ahead
Fridays low brought the Russell 200 close to major support from the 50-DMA at $210.95. This area coincides with consolidation from mid to late January. If the market takes a negative turn Monday,... 
Tags Consumer Goods Financial Transportation
From Blogs - TalkMarkets
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags OPNT IMCR KMPH
From Benzinga
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ICPT INCY SUPN
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MDWD PBYI DVAX
From Benzinga
The Importance of the 50-Day Moving Average
Looking forward, ideally, QQQs should hold the 50-DMA at 320, although we would have a stop under Tuesday’s low or under 311 to give it some room. 
Tags ETFs Market News
From Blogs - TalkMarkets
Biotech ETFs Pop Amid Pending J&J Vaccine Approval
Biotech ETFs are climbing Wednesday as the Food and Drug Administration’s staff endorsed Johnson & Johnson’s coronavirus vaccine for emergency use, a key step in offering a third vaccination to the... 
Tags JNJ Principal Featured
From ETF Trends
Buy on the Dip Prospects: February 24 Edition
Here is a look at ETFs that currently offer attractive short buying opportunities. The ETFs included in this list are rated as buy candidates for two reasons. First, each of these funds is deemed to be... 
From ETFdb
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GH NEO IONS
From Benzinga
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PHAR OFIX Biotech
From Benzinga
Noteworthy ETF Inflows: IBB, GILD, MRNA, ILMN
Symbols mentioned in this story: IBB, GILD, MRNA, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Two Growing Sectors With Huge Potential
Despite worry of a pending market correction, talks of stimulus and an infrastructure package paired with a supportive Federal Reserve helped boost market moral this week. 
Tags Energy Market News Transportation
From Blogs - TalkMarkets
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags CNCE MDT NKTR
From Benzinga
ETF Flows Report for 02/19/2021
. orttr { font-family: Arial; font-size: 12pt; font-weight: bold; height: 24px; } . 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CLDX Top Stories SANA
From Benzinga
Is This Cheap Cancer-Drug Company a Top Stock to Buy Now?
Large biotechs are taking over small-cap companies (and their cancer treatments) left and right. Could this business be the next target? 
Tags Market News IBB TGTX
From Motley Fool
3 Biotech Stocks to Buy As Things Heat Up for the Sector
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biotech stocks offer a textbook retracement pattern. The risk is low, and... 
Tags GILD NYSE:BSX, NYSEARCA:XBI, NASDAQ:IBB, NASDAQ:AMGN, NASDAQ:GILD, NASDAQ:MRNA BSX
From InvestorPlace
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IMNM IART ORMP
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks AEZS NARI
From Benzinga
Transports And Small Caps Lead Market Direction
Watching IWM instead of larger indices, like the S&P 500 is a better way to grasp the overall market recovery, as IWM represents 2000 small cap companies, while the S&P 500 represents only 500 large... 
Tags ETFs
From Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap ... 
Tags IART OCGN AVNS
From Benzinga
Illumina Earnings, Forward Guidance Strengthen Biotech ETFs
Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck... 
Tags Health Care Innovative ETFs Channel iShares
From ETF Trends
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONCT PRTA PAVM
From Benzinga
We Did The Math IBB Can Go To $187
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.